Cost-Utility Analysis Of Tocilizumab In The Treatment Of Active Systemic Juvenile Idiopathic Arthritis
Abstract
Authors
C. Vicente S. Sabapathy L. Formica B. Maturi C. Piwko
C. Vicente S. Sabapathy L. Formica B. Maturi C. Piwko
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now